SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-655870
Filing Date
2016-07-25
Accepted
2016-07-25 07:00:32
Documents
2
Group Members
BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE

Document Format Files

Seq Description Document Type Size
1 SC 13G d222679dsc13g.htm SC 13G 58957
2 EX-99.1 d222679dex991.htm EX-99.1 3350
  Complete submission text file 0001193125-16-655870.txt   63929
Mailing Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102
Business Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102 (973) 242-0005
Neurotrope, Inc. (Subject) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88549 | Film No.: 161780900
SIC: 2834 Pharmaceutical Preparations

Mailing Address 364 PATTESON DRIVE, #279 MORGANTOWN WV 26505
Business Address 364 PATTESON DRIVE, #279 MORGANTOWN WV 26505 304-598-8112
Neurosciences Research Ventures, Inc. (Filed by) CIK: 0001618058 (see all company filings)

IRS No.: 550771180 | State of Incorp.: WV | Fiscal Year End: 1231
Type: SC 13G